These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26316468)

  • 1. Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.
    Deekonda S; Rankin D; Davis P; Lai J; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4148-52. PubMed ID: 26316468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ala scan analogues of HOE 140. Synthesis and biological activities.
    Quartara L; Ricci R; Meini S; Patacchini R; Giolitti A; Amadesi S; Rizzi C; Rizzi A; Varani K; Borea PA; Maggi CA; Regoli D
    Eur J Med Chem; 2000 Nov; 35(11):1001-10. PubMed ID: 11137228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.
    Yamamoto T; Nair P; Vagner J; Largent-Milnes T; Davis P; Ma SW; Navratilova E; Moye S; Tumati S; Lai J; Yamamura HI; Vanderah TW; Porreca F; Hruby VJ
    J Med Chem; 2008 Mar; 51(5):1369-76. PubMed ID: 18266313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of bradykinin receptors in a human osteoblastic cell line.
    Brechter AB; Lerner UH
    Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
    J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.
    Yamamoto T; Nair P; Davis P; Ma SW; Navratilova E; Moye S; Tumati S; Lai J; Vanderah TW; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 2007 Jun; 50(12):2779-86. PubMed ID: 17516639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.
    Agnes RS; Lee YS; Davis P; Ma SW; Badghisi H; Porreca F; Lai J; Hruby VJ
    J Med Chem; 2006 May; 49(10):2868-75. PubMed ID: 16686530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
    Meini S; Lecci A; Maggi CA
    Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin receptor types and B2 subtypes.
    Regoli D; Gobeil F; Nguyen QT; Jukic D; Seoane PR; Salvino JM; Sawutz DG
    Life Sci; 1994; 55(10):735-49. PubMed ID: 8072371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
    Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
    Eur J Pharmacol; 1992 Mar; 225(3):235-44. PubMed ID: 1325366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.
    Meini S; Lecci A; Carini F; Tramontana M; Giuliani S; Maggi CA; Ricci R; Fabbri G; Anichini B; Harmat N; Rizzi A; Camarda V; Regoli D; Quartara L
    Can J Physiol Pharmacol; 2002 Apr; 80(4):293-302. PubMed ID: 12025964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.
    Deekonda S; Wugalter L; Rankin D; Largent-Milnes TM; Davis P; Wang Y; Bassirirad NM; Lai J; Kulkarni V; Vanderah TW; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4683-8. PubMed ID: 26323872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety.
    Amblard M; Daffix I; Bedos P; Bergé G; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Dodey P; Martinez J
    J Med Chem; 1999 Oct; 42(20):4185-92. PubMed ID: 10514288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new generation of bradykinin antagonists.
    Stewart JM; Gera L; Hanson W; Zuzack JS; Burkard M; McCullough R; Whalley ET
    Immunopharmacology; 1996 Jun; 33(1-3):51-60. PubMed ID: 8856115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.